Morphea (Localized Scleroderma): Symptoms, Diagnosis, and Treatment

Morphea, also called localized scleroderma, causes areas of inflammation and hardening in the skin and sometimes the tissue beneath it. It is distinct from systemic sclerosis, but deeper or linear forms can affect movement, growth, or structures under the skin. This guide explains its patterns, assessment, treatment options, and signs that merit medical review.

Medical information: This article is educational and cannot diagnose morphea or replace care from a qualified clinician. Treatment decisions depend on the individual pattern, depth, activity, location, and health history.

A practical definition

Morphea is a rare inflammatory condition that leads to localized thickening and hardening of the skin. It is also called localized scleroderma or, in some medical references, morphoea. The word “scleroderma” describes skin hardening, but the name can be confusing: morphea is not the same disease as systemic sclerosis. Morphea usually forms one or more defined areas, and its effects are concentrated in skin and nearby tissues. Depending on subtype, depth, and location, it can involve the layer of fat under the skin, connective tissue around muscles, muscle, or bone.

The condition can occur at any age, including childhood. Its appearance and course vary: some people have a single superficial patch, while others develop multiple areas or a long band of disease that reaches deeper tissues. Some lesions become inactive over time but leave a lasting change in color, texture, or volume. “Localized” therefore describes the distribution and usual pattern; it does not mean every case is shallow or functionally unimportant.

Clinicians distinguish morphea from systemic sclerosis because the expected assessment and complications differ. Systemic sclerosis can affect blood vessels and internal organs such as the lungs, heart, kidneys, or digestive tract. Morphea does not typically cause that pattern of internal-organ fibrosis, although a deeper lesion can affect structures immediately beneath the involved skin and rare craniofacial forms can have eye, dental, or neurologic associations. The diagnosis should be based on the whole clinical picture.

How morphea may look and feel

Early active lesions may start as pink, red, or violaceous areas of swelling or inflammation. The color can be subtle on darker skin and may appear as a change in tone rather than obvious redness. A pale or waxy-looking center can develop, sometimes surrounded by a pink or lilac rim. As inflammation progresses, the center may feel firm, smooth, tight, or bound down. Hair and sweat production can be reduced within affected skin.

Later, the skin may soften as the inflammatory phase settles, yet still look darker, lighter, shiny, thin, or indented compared with surrounding skin. The area can lose subcutaneous fat and appear depressed. A change in pigment or contour does not necessarily mean active inflammation is still present. Clinicians consider symptoms, examination, photographs over time, and sometimes imaging to distinguish active disease from residual damage.

Some people notice itching, tenderness, aching, or a sensation of tightness; others have no discomfort. A patch on the trunk may be mainly a visible skin change, while a lesion near a wrist, elbow, ankle, knee, or shoulder can matter because the skin and deeper tissues move with the joint. A long lesion over a growing limb may need careful monitoring for asymmetry or restricted movement.

Recognized patterns and subtypes

Plaque morphea is a common form. It often consists of one or several oval or round patches on the trunk or limbs. These areas are usually limited to skin and the immediately underlying tissue, although depth varies. Plaque lesions may have a lilac or pink edge when active and a smooth, firmer center. Multiple lesions over a broad area may be described as generalized morphea.

Linear morphea forms a band or line of altered skin. It is particularly important in children and young people because it can extend below the skin, affect growth, or cross a joint. A lesion on an arm or leg can cause tightness or a difference in limb circumference or length. A line on the forehead or scalp is sometimes described as en coup de sabre; a related pattern can involve one side of the face. These craniofacial patterns may warrant coordinated dermatology, eye, dental, neurology, or other specialist assessment depending on symptoms and extent.

Deep morphea describes disease that reaches deeper connective tissues, such as the fascia or muscle, and sometimes structures nearer bone. The surface may look less dramatic than the depth of involvement would suggest. A deep lesion can cause tethering, pain, weakness, reduced range of motion, or a contracture. Generalized disease describes multiple plaques over several body areas; the term does not itself establish how deep each patch is.

Morphea is classified in more than one way, and clinicians may use overlapping labels to describe distribution and depth. A subtype label is a useful shorthand, not a complete forecast. Location, age, current activity, depth, and effects on movement all influence the practical plan.

Why the pattern matters

Location changes what a clinician looks for. A small stable plaque on the trunk may primarily need confirmation, skin care, and observation. A linear lesion that follows a limb, crosses a joint, involves the scalp or face, or is associated with a movement change raises different questions about depth and function. Children may need monitoring during growth even when symptoms are mild, because growth-related changes can emerge gradually.

On the face or scalp, the clinician may ask about headaches, seizures, altered sensation, weakness, vision changes, dental development, or facial asymmetry. These symptoms can have many causes and do not prove that morphea has affected deeper structures. They do, however, help determine whether additional examination or imaging is appropriate. There is no single set of tests that every person needs.

On a limb, examination may compare motion, limb size, strength, and function on both sides. Photos taken in similar lighting and position can help document whether the edge or contour is changing. If a joint is involved, clinicians may consider physical or occupational therapy to preserve safe movement and daily function. Stretching or exercise should be individualized when a lesion is tight or painful.

Possible effects beyond the visible patch

A visible patch can affect confidence, clothing choices, and comfort in social situations. People may feel worried when a lesion changes quickly or when the word “scleroderma” is mentioned. Clear explanation of the diagnosis, subtype, and the specific findings being monitored can reduce avoidable uncertainty. Emotional support or counseling can be useful when appearance-related distress is affecting everyday life.

Skin tightness over a joint can gradually limit movement. In deeper linear disease, changes in underlying tissue can contribute to muscle weakness, contracture, or asymmetry. In a growing child, involvement of a limb may affect development of the nearby tissues or bone. A craniofacial lesion may leave changes in skin or underlying volume and, in some cases, needs evaluation for associated eye, dental, or neurologic issues. These risks are not present in every person with morphea.

Morphea itself is not contagious. It is not caused by unclean skin, and ordinary contact with another person cannot transmit it. The biological cause is not fully established. Research points to a complex inflammatory process, but no single trigger explains all cases. A clinician can discuss whether a possible preceding event is relevant without assuming it caused the condition.

How clinicians assess a suspected case

Assessment begins with a history and examination. A clinician asks when the area first appeared, how it has changed, whether there are new lesions, and whether the skin feels itchy, painful, tight, or numb. They may ask about movement, strength, growth, and symptoms involving the face, scalp, eyes, mouth, or nervous system. Photographs and a skin map can make follow-up comparisons more reliable.

The examination considers shape, color, firmness, temperature, texture, pigment, hair growth, and whether the skin moves freely over tissue beneath it. The clinician may check the range of motion of nearby joints and compare the affected side with the other side. In children, growth and symmetry may be followed over time. If features are atypical, alternative diagnoses such as another inflammatory skin disorder, an infection, a scar, or a different cause of skin thickening may need to be considered.

A skin biopsy is not required in every typical presentation. A clinician may recommend it when the appearance is uncertain or another diagnosis needs to be excluded. The sample can show changes that support morphea, but results are interpreted alongside the history and examination. Blood tests do not independently confirm morphea. They may be chosen to answer a particular question, assess another suspected condition, or establish a baseline before some prescription treatments.

Imaging is also selected according to the question. MRI can help assess deeper tissue involvement, particularly for a linear lesion near a joint or a craniofacial lesion when examination suggests a deeper extent. Imaging is not automatically needed for every superficial patch. A referral to another specialist may be appropriate when the location or symptoms involve a joint, growing limb, face, eye, teeth, or nervous system.

Treatment is matched to activity, depth, and location

Not every lesion requires the same treatment, and the plan can change as disease activity changes. The clinician weighs whether the lesion is active or inactive, how extensive it is, how deep it appears, where it is located, and whether it threatens movement, growth, or important structures. Treatment aims to control active inflammation and reduce the chance of further tissue damage. It may not fully reverse a lasting indentation or pigment change after inflammation has stopped.

For a limited, superficial plaque, a clinician may recommend observation, skin care, or a prescribed topical medicine. Depending on the case, treatments applied to the skin may include corticosteroids or other anti-inflammatory medicines. These medicines have potential side effects, so the clinician should specify where, how much, and for how long to use them. Do not apply a prescription product to a large area or sensitive site without medical direction.

Phototherapy may be considered for selected superficial or widespread skin disease. It uses a controlled medical light source under a treatment schedule. Suitability depends on subtype, depth, age, skin characteristics, access, and individual risks. Phototherapy may be less useful when disease extends far beneath the skin, and it requires clinician oversight.

More active, deep, linear, or function-threatening disease may be treated with prescription medicines that work throughout the body. Methotrexate, sometimes combined with a limited course of corticosteroids, is among the approaches used for more significant disease; other immune-modulating medicines may be considered when appropriate. These treatments require a specialist, individualized discussion of benefits and risks, and laboratory or clinical monitoring where indicated. The right choice depends on the person and the disease pattern.

Rehabilitation can support safe range of motion and function when tightness or joint involvement is present. A physical or occupational therapist can tailor exercises and practical adaptations. They can also help identify functional changes early. Therapy supports the overall plan but does not replace evaluation of active disease. Avoid forceful stretching of a painful or tight area without advice from a clinician who understands the lesion.

Daily skin care and practical support

Use a gentle, fragrance-free cleanser and a moisturizer if the skin is dry or uncomfortable. Avoid picking, vigorous rubbing, or unprescribed harsh treatments on an affected area. Sun protection can help reduce additional color contrast and protect exposed skin, although sunscreen does not treat morphea itself. If a lesion is sensitive, comfortable clothing and avoiding repeated friction may help.

Track meaningful changes rather than checking the area constantly. A dated photograph taken in consistent lighting and at a consistent distance can make gradual differences easier to discuss. Note new patches, spread, a change in firmness, increasing tightness, pain, numbness, or a change in joint movement. For a child, record growth or functional concerns and share them at follow-up.

Ask the treating clinician what signs indicate active disease for this particular lesion, what should prompt an earlier appointment, and who to contact between visits. It is reasonable to ask how the chosen treatment will be monitored and when the plan will be reviewed. If a medicine is prescribed, discuss side effects, pregnancy considerations where relevant, interactions, and monitoring before starting or changing it.

Cosmetic camouflage or supportive clothing may help some people feel more comfortable, but it is optional. If the patch is visible or the diagnosis is affecting mood, ask about dermatology support, counseling, or patient groups. The aim is to address both the skin condition and its effect on daily life.

When to arrange prompt review

Seek timely medical assessment for a new, enlarging, or increasingly firm area, particularly if it forms a line on an arm or leg, crosses a joint, lies on the forehead or scalp, or is associated with reduced movement. A previously diagnosed lesion that is changing after a period of stability deserves review. The clinician can decide whether the change represents renewed activity, residual damage, or something else.

Arrange prompt assessment for facial or scalp morphea accompanied by new vision symptoms, eye pain, significant headache, seizure, weakness, altered sensation, or a change in facial movement. These symptoms do not necessarily come from morphea, but they need appropriate clinical evaluation. Sudden severe neurologic symptoms should be handled as an emergency according to local emergency services.

Urgent care is also appropriate for a rapidly worsening loss of function, severe pain, or symptoms that suggest an unrelated emergency. For non-urgent concerns, contact the clinician managing the skin condition rather than beginning leftover prescription treatment. Early review can help identify the right next step.

Course and follow-up

The course differs from person to person. Some limited lesions gradually become inactive; more extensive or deeper disease can require prolonged treatment and monitoring. In many cases, inflammation eventually settles, but the skin can retain a change in color, texture, thickness, or volume. An inactive area may not return to its original appearance, and cosmetic or functional concerns can persist even after active inflammation ends.

Relapse or development of new lesions is possible. A period of stability is reassuring but does not guarantee that no further change will occur. Follow-up frequency depends on activity, subtype, depth, age, treatment, and functional risk. A person receiving systemic medicines may need monitoring that differs from someone whose small superficial patch is being observed.

At follow-up, the clinician may compare photographs, measure affected areas, examine firmness and color, and repeat movement or growth assessments. Imaging may be revisited if symptoms or examination change. The purpose is to detect activity or deeper effects early enough to adjust care. Ask for a written summary of the diagnosis and plan, especially if more than one specialist is involved.

Questions to discuss with a clinician

Useful questions include: Which subtype best describes my lesion? Does it appear active now, and what findings support that view? Is there evidence of deeper tissue involvement? What changes should I monitor at home? Does the location justify imaging or another specialist? What are the expected benefits and possible downsides of the proposed treatment? How will we know whether it is working? When should I return, and what would make you want to see me sooner?

For parents and caregivers, ask how the lesion might affect growth, limb movement, school activities, and sports. Ask whether a physical or occupational therapist should assess function. For facial or scalp disease, ask whether eye, dental, or neurologic review is appropriate based on the child’s pattern and symptoms. A clear follow-up plan is more useful than trying to predict the entire course from one appointment.

Key takeaways

Morphea is localized skin and connective-tissue sclerosis with several patterns, from superficial plaques to deeper linear disease. It is distinct from systemic sclerosis, although a deep lesion or a lesion on the face, scalp, growing limb, or near a joint may need careful assessment. Diagnosis is usually based on clinical evaluation, with biopsy or imaging used selectively. Treatment ranges from observation and topical approaches to phototherapy or systemic prescription therapy, depending on activity and risk. Follow-up focuses on skin change, function, growth, and the possibility of new activity. This article is for education and cannot determine an individual diagnosis or treatment.

Frequently asked questions

Sources and further reading

These clinical and patient resources informed this overview. They provide general information; a treating clinician can interpret findings for an individual case.

• DermNet: Morphoea
• National Institute of Arthritis and Musculoskeletal and Skin Diseases: Scleroderma
• NIAMS: Scleroderma diagnosis, treatment, and steps to take
• Great Ormond Street Hospital: Morphoea
• NHS: Scleroderma

Editorial note: This article distinguishes localized morphea from systemic sclerosis while recognizing that deeper or craniofacial morphea can need additional assessment. Do not start, stop, or change prescription treatment based only on this page.